Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Diabetes

Journal Scan / Research · January 24, 2024

Real-World Use of Control-IQ Technology Is Associated With Lower Rates of Severe Hypoglycemia and Diabetic Ketoacidosis

Diabetes Technology & Therapeutics

 

Additional Info

Diabetes Technology & Therapeutics
Real-World Use of Control-IQ Technology Is Associated with a Lower Rate of Severe Hypoglycemia and Diabetic Ketoacidosis Than Historical Data: Results of the Control-IQ Observational (CLIO) Prospective Study
Diabetes Technol. Ther. 2024 Jan 01;26(1)24-32, R Graham, L Mueller, M Manning, S Habif, LH Messer, JE Pinsker, E Aronoff-Spencer

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading